Schedule 13G ownership disclosure

TETRAPHASE PHARMA

Security class unavailable · CUSIP: 88165N204

Event date: 2020-01-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
666,666
Percent of class
9.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-009163
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
Jan 31, 2020
Reporting period
Jan 22, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub